Securities and Exchange Commission

Effective Income Tax Rate Reconciliation, Deduction, Medicare Prescription Drug Benefit, Percent

Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for Medicare prescription drug benefit subsidy.

Compare To Other Companies

Annual (pure)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
0.105	2022-05-09	20-F	2021	FY	2021-01-01	2021-12-31	CY2021
0.105	2023-05-12	20-F	2022	FY	2022-01-01	2022-12-31	CY2022
0.105	2024-04-30	20-F	2023	FY	2023-01-01	2023-12-31	CY2023

All Reported Effective Income Tax Rate Reconciliation, Deduction, Medicare Prescription Drug Benefit, Percent (pure)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
0.105	2022-05-09	20-F	2021	FY	2021-01-01	2021-12-31	CY2021
0.105	2023-05-12	20-F	2022	FY	2022-01-01	2022-12-31	CY2022
0.105	2024-04-30	20-F	2023	FY	2023-01-01	2023-12-31	CY2023